Sanofi bought Dren’s DR-0201 program earlier this year for $600 million upfront and is running two Phase I trials in ...

Explore how Nobel laureates Ilya Mechnikov and Paul Ehrlich revolutionized immunology, shaping modern medicine and public ...

In a newly published review, Professor Xiao-Jun Huang's team at Peking University People's Hospital explore how haploidentical hematopoietic stem cell transplantation (haplo-HSCT), once limited by ...

Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...

As 2025 closes out, a pair of autoimmune biotechs have eked out separate deals with Big Pharma before year-end, each with a sizable potential payout down the line. | Seattle’s Adaptive Biotechnologies ...

Scientists have discovered that T cell receptors activate through a hidden spring-like motion that had never been seen before ...

Dren Bio retains the option to co-fund future development in exchange for U.S. co-promotion rights with Sanofi, a 50/50 share ...

Antibiotic resistance is a growing global health crisis that makes common infections harder to treat and puts many medical ...

Rutgers researchers found that the distribution of neural timescales across the cortex plays a crucial role in how ...

Researchers at ETH Zurich recently explained the role of a molecular complex that orchestrates the production of proteins in ...

Researchers are striving to understand the impact a phenomenon known as original antigenic sin has on immunity to the virus.

A hidden “jack-in-the-box” mechanism inside T cells may hold the key to unlocking more powerful cancer immunotherapies.